Cord Blood T Cells Fight Solid Tumors | Science News

Scientists at UCLA have unlocked a revolutionary cancer treatment by engineering T cells from donated cord blood — creating an “off-the-shelf” therapy that outperforms current methods. In mice, a single dose halted tumors, extended survival, and avoided dangerous side effects. Unlike traditional therapies that require custom patient-specific cells, these pre-made cells can be stored and rapidly deployed, slashing costs and wait times. The breakthrough uses immature stem cells from cord blood, engineered to target cancer with precision while avoiding harmful natural receptors. Even better, the cells feature a dual detection system: they attack tumors via engineered receptors AND natural killer cell receptors, helping them overcome solid tumors’ ability to hide or mutate. While mouse results are thrilling, human trials are still needed — but this could soon redefine how we fight cancer. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9f06b561fcce56a8